Klaus Stoeckemann
Managing Director & Co-Founder @ Peppermint Venture Partners
Berlin, Germany
Klaus Stoeckemann is a Series A investor at Peppermint Venture Partners in Berlin focused on Medical and Wellness. Dr. Klaus Stöckemann, Ph.D. in Biology and Pharmacology from the University of Mainz as well as M.B.A. from WHU (Koblenz) and Kellogg Northwestern University (US); managing partner & co-founder of Peppermint VenturePartners which is focusing on medical device start-up investments in Germany and throughout Europe; many years of leading roles atSchering AG und ASTA Medica in R&D and Business Development; more than 13 years of experience in the Venture Capital Industry with a focus on Medical Devices and Health IT; chairman of the boards of Humedics and board member of Implandata Ophthalmic Products.
- Total investments:
- 3
- Last investment:
- Lead investor:
- 33%
Last updated:
For AI agents: llms.txt
Industries Klaus Stoeckemann invests in
Stages Klaus Stoeckemann invests in
Countries Klaus Stoeckemann invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Medical 1 (33%)
- Wellness 1 (33%)
- Health Care 1 (33%)
- Medical Device 1 (33%)
Stage
- Series A 1 (33%)
- Series B 1 (33%)
- Series C 1 (33%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Implandata Ophthalmic Products is an early stage, privately-held, venture capital funded medical device company based in Hannover, Germany. Implandata Ophthalmic Products is a medical device company offering a new technology for the treatment and management of glaucoma patients. It identifies an underserved area in care of glaucoma patients,creating disruptive solutions for better and more efficient glaucoma therapy, to the benefit of glaucoma patients, families, and care givers by integrating innovative medical technology with information technology.IOP has developed a novel technology for 24 hour measurement of intraocular pressure, by which monitoring and therapy of glaucoma patients will be improved. This solution will allow a more efficient treatment and management of glaucoma patients.Implandata Ophthalmic Products was founded on 2010. | Series C / May 14, 2018 | ||
| Implandata Ophthalmic Products is an early stage, privately-held, venture capital funded medical device company based in Hannover, Germany. Implandata Ophthalmic Products is a medical device company offering a new technology for the treatment and management of glaucoma patients. It identifies an underserved area in care of glaucoma patients,creating disruptive solutions for better and more efficient glaucoma therapy, to the benefit of glaucoma patients, families, and care givers by integrating innovative medical technology with information technology.IOP has developed a novel technology for 24 hour measurement of intraocular pressure, by which monitoring and therapy of glaucoma patients will be improved. This solution will allow a more efficient treatment and management of glaucoma patients.Implandata Ophthalmic Products was founded on 2010. | $3.3M / Series B / Oct 27, 2014 | ||
| Implandata Ophthalmic Products is an early stage, privately-held, venture capital funded medical device company based in Hannover, Germany. Implandata Ophthalmic Products is a medical device company offering a new technology for the treatment and management of glaucoma patients. It identifies an underserved area in care of glaucoma patients,creating disruptive solutions for better and more efficient glaucoma therapy, to the benefit of glaucoma patients, families, and care givers by integrating innovative medical technology with information technology.IOP has developed a novel technology for 24 hour measurement of intraocular pressure, by which monitoring and therapy of glaucoma patients will be improved. This solution will allow a more efficient treatment and management of glaucoma patients.Implandata Ophthalmic Products was founded on 2010. | $1.8M / Series A / Aug 30, 2012 |
Co-Investors
PVP is a private venture capital firm based in Berlin, investing in early-stage healthcare companies across Europe with a focus on medical device, digital health, and platform technology companies. Peppermint VenturePartners was established in 2008 by Ingeborg Neumann, Dr. Joachim Rautter and Dr. Klaus Stöckemann.
Peppermint Venture Partners Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Joachim Rautter
Co-Founder and Managing Director
|
|||
|
Klaus Stoeckemann
Managing Director & Co-Founder
|
|||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Klaus Stoeckemann invest in?
Klaus Stoeckemann invests primarily in Medical, Wellness and Health Care startups, most often at Series A and Series B stage. Most of the 3 investments tracked by Shizune back companies in Germany. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Klaus Stoeckemann?
Public channels for Klaus Stoeckemann include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Klaus Stoeckemann last invest?
The most recent investment recorded for Klaus Stoeckemann closed in May 2018. Shizune tracks 3 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
